PEAK6 Group’s Kite Pharma, Inc. KITE Stock Holding History

PEAK6 Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,680	Closed	-$4.08M	–	5240
2017 Q3	$4.08M	Buy	+22,680	New	+$3.16M	0.02%	882
2016 Q3	–	Sell	-2,039	Closed	-$102K	–	5021
2016 Q2	$102K	Buy	+2,039	New	+$100K	﹤0.01%	3565
2016 Q1	–	Sell	-1,000	Closed	-$48.4K	–	5425
2015 Q4	$62K	Buy	+1,000	New	+$70.4K	﹤0.01%	4190

PEAK6 Group's KITE Position: Q4 2017 in Review

PEAK6 Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 22,680 shares — an estimated $4.08M sold.

PEAK6 Group first reported a position in KITE in Q4 2015 and held it in 3 quarters. The position peaked at $4.08M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

PEAK6 Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
PEAK6 Group sold 22,680 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.08M.
PEAK6 Group first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 3 quarters.
PEAK6 Group's Kite Pharma, Inc. position peaked at $4.08M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.